Beam Therapeutics Inc.
BEAM
31 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Jan 30 9:12 PM | JOHN M EVANS | Proposed Sale | 30,000 | $26.75 | $802.5K | — | View → |
| Dec 31, 2024 | Dec 31 12:29 AM | BETHANY J. CAVANAGH | Proposed Sale | 9,500 | $25.27 | $240.1K | — | View → |
| Dec 31, 2024 | Dec 31 12:26 AM | CHRISTINE BELLON | Proposed Sale | 4,167 | $25.27 | $105.3K | — | View → |
| Oct 14, 2024 | Oct 15 3:37 PM | Giuseppe Ciaramella | Proposed Sale | 102,220 | $24.65 | $2.5M | — | View → |
| Oct 7, 2024 | Oct 7 9:00 PM | Burrell Terry-Ann | Proposed Sale | 185,565 | $23.00 | $4.3M | — | View → |
| Sep 30, 2024 | Sep 30 8:51 PM | JOHN M EVANS | Proposed Sale | 60,000 | $24.60 | $1.5M | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 205,804(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 230,804(D) | View → |
| Jun 17, 2026 | Jun 22 8:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,505 | $1.03 | 56,946(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Christi ShawDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Kathleen E WalshDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | John MaraganoreDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Mark FishmanDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Chirfi GuindoDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Graham K CooperDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Mar 31, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 18,672(D) | View → |
| Mar 30, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 43,672(D) | View → |
| Feb 24, 2026 | Feb 26 9:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,000 | $17.00 | 397,313(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Giuseppe CiaramellaPresident | Grant/Award | 80,000 | $27.62 | 80,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Sravan Kumar EmanyChief Financial Officer | Grant/Award | 63,500 | $27.62 | 63,500(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Christine BellonChief Legal Officer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Grant/Award | 180,000 | $27.62 | 180,000(D) | View → |
| Jan 30, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 68,672(D) | View → |
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 93,672(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Amy SimonChief Medical Officer | Grant/Award | 88,500 | $27.62 | 88,500(D) | View → |